Protocol Design White Papers & Case Studies

1. DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS 6/18/2026

   How does the DECODE CRS Coalition help trial sponsors standardize protocols and build a first-of-its-kind wearable dataset to lower development costs and safely de-risk outpatient care?

2. Adherence Monitoring Solutions: Choose The Right Level Of Support 6/18/2026

   Help your study team curb trial costs and delays by monitoring adherence in near real time. These tools automate reporting and issue alerts to maximize data capture and regulatory readiness.

3. Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction 6/15/2026

   Centralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.

4. A Mission To Expand Recruitment Territory 6/11/2026

   Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.

5. Improving Compliance and Scale in Research Pharmacy Workflows 6/10/2026

   Modernize research pharmacy operations with digital workflows that reduce manual effort, improve compliance, strengthen audit readiness, and help sites support more protocols with confidence.

6. Vestigo Features FAQ 6/10/2026

   Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.

7. Demonstrating IDS Value With Time-Based Metrics 6/10/2026

   Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

8. Building A Scalable Oncology Engine In A Dynamic Market 6/3/2026

   Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.

9. Navigating The Challenges Of Large, International Phase III Breast Cancer Trials 5/27/2026

   In the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.

10. De-Risking The Neurology IND: Lessons From Early FDA Engagement 5/27/2026

    Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.